Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TYK Medicines, Inc. Class H ( (HK:2410) ) has provided an announcement.
TYK Medicines, Inc has announced that its H shares will be included in the Hang Seng Biotech Index starting June 9, 2025. This inclusion is seen as a recognition of the company’s strong business performance and growth prospects, expected to expand its shareholder base, increase trading liquidity, and enhance its reputation and brand awareness.
More about TYK Medicines, Inc. Class H
TYK Medicines, Inc is a biotechnology company based in the People’s Republic of China, focusing on the development and commercialization of innovative medical treatments. The company is listed on the Hong Kong Stock Exchange and is involved in the biotech industry, aiming to enhance its market presence and shareholder value.
Average Trading Volume: 2,104,959
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$8.66B
Learn more about 2410 stock on TipRanks’ Stock Analysis page.